Insider Transactions in Q2 2023 at Moon Lake Immunotherapeutics (MLTX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
800,000
+13.97%
|
$40,000,000
$50.0 P/Share
|
|
Jun 26
2023
|
Bihua Chen |
BUY
Open market or private purchase
|
Indirect |
450,000
+0.42%
|
$23,400,000
$52.64 P/Share
|
|
Apr 05
2023
|
Kristian Reich Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
98,090
-29.16%
|
-
|
|
Apr 05
2023
|
Kristian Reich Chief Scientific Officer |
BUY
Conversion of derivative security
|
Direct |
98,090
+50.0%
|
-
|
|
Apr 05
2023
|
Kristian Reich Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
500,006
-16.52%
|
-
|
|
Apr 05
2023
|
Kristian Reich Chief Scientific Officer |
BUY
Conversion of derivative security
|
Indirect |
500,006
+50.0%
|
-
|
|
Apr 05
2023
|
Matthias Bodenstedt Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
557,931
-64.58%
|
-
|
|
Apr 05
2023
|
Matthias Bodenstedt Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
557,931
+35.43%
|
-
|